Cargando…

Updating the biologically based dose-response model for the nasal carcinogenicity of inhaled formaldehyde in the F344 rat

Chronic inhalation of formaldehyde by F344 rats causes nasal squamous cell carcinoma (SCC). This outcome is well-characterized: including dose-response and time course data for SCC, mechanistic endpoints, and nasal dosimetry. Conolly et al. (Toxicol. Sci. 75, 432–447, 2003) used these resources to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Conolly, Rory B, Schroeter, Jeffry, Kimbell, Julia S, Clewell, Harvey, Andersen, Melvin E, Gentry, P Robinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176246/
https://www.ncbi.nlm.nih.gov/pubmed/36912747
http://dx.doi.org/10.1093/toxsci/kfad028
_version_ 1785040389881724928
author Conolly, Rory B
Schroeter, Jeffry
Kimbell, Julia S
Clewell, Harvey
Andersen, Melvin E
Gentry, P Robinan
author_facet Conolly, Rory B
Schroeter, Jeffry
Kimbell, Julia S
Clewell, Harvey
Andersen, Melvin E
Gentry, P Robinan
author_sort Conolly, Rory B
collection PubMed
description Chronic inhalation of formaldehyde by F344 rats causes nasal squamous cell carcinoma (SCC). This outcome is well-characterized: including dose-response and time course data for SCC, mechanistic endpoints, and nasal dosimetry. Conolly et al. (Toxicol. Sci. 75, 432–447, 2003) used these resources to develop a biologically based dose-response (BBDR) model for SCC in F344 rats. This model, scaled up to humans, has informed dose-response conclusions reached by several international regulatory agencies. However, USEPA concluded that uncertainties precluded its use for cancer risk assessment. Here, we describe an updated BBDR model that addresses uncertainties through refined dosimetry modeling, revised analysis of labeling index data, and an extended dataset where both inhaled (exogenous) and endogenous formaldehyde (exogF, endoF) form DNA adducts. Further, since Conolly et al. (ibid) was published, it has become clear that, when controls from all F344 inhalation bioassays are considered, accounting for over 4000 rats, at most one nasal SCC occurred. This low spontaneous incidence constrains possible contribution of endoF to the formation of nasal SCC via DNA reactivity. Further, since both exogF and endoF form DNA adducts, this constraint also applies to exogF. The revised BBDR model therefore drives SCC formation through the cytotoxicity of high concentration exogF. An option for direct mutagenicity associated with DNA adducts is retained to allow estimation of an upper bound on adduct mutagenicity consistent with the lack of a spontaneous SCC incidence. These updates represent an iterative refinement of the 2003 model, incorporating new data and insights to reduce identified model uncertainties.
format Online
Article
Text
id pubmed-10176246
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101762462023-05-13 Updating the biologically based dose-response model for the nasal carcinogenicity of inhaled formaldehyde in the F344 rat Conolly, Rory B Schroeter, Jeffry Kimbell, Julia S Clewell, Harvey Andersen, Melvin E Gentry, P Robinan Toxicol Sci Biotransformation, Toxicokinetics, and Pharmacokinetics Chronic inhalation of formaldehyde by F344 rats causes nasal squamous cell carcinoma (SCC). This outcome is well-characterized: including dose-response and time course data for SCC, mechanistic endpoints, and nasal dosimetry. Conolly et al. (Toxicol. Sci. 75, 432–447, 2003) used these resources to develop a biologically based dose-response (BBDR) model for SCC in F344 rats. This model, scaled up to humans, has informed dose-response conclusions reached by several international regulatory agencies. However, USEPA concluded that uncertainties precluded its use for cancer risk assessment. Here, we describe an updated BBDR model that addresses uncertainties through refined dosimetry modeling, revised analysis of labeling index data, and an extended dataset where both inhaled (exogenous) and endogenous formaldehyde (exogF, endoF) form DNA adducts. Further, since Conolly et al. (ibid) was published, it has become clear that, when controls from all F344 inhalation bioassays are considered, accounting for over 4000 rats, at most one nasal SCC occurred. This low spontaneous incidence constrains possible contribution of endoF to the formation of nasal SCC via DNA reactivity. Further, since both exogF and endoF form DNA adducts, this constraint also applies to exogF. The revised BBDR model therefore drives SCC formation through the cytotoxicity of high concentration exogF. An option for direct mutagenicity associated with DNA adducts is retained to allow estimation of an upper bound on adduct mutagenicity consistent with the lack of a spontaneous SCC incidence. These updates represent an iterative refinement of the 2003 model, incorporating new data and insights to reduce identified model uncertainties. Oxford University Press 2023-03-13 /pmc/articles/PMC10176246/ /pubmed/36912747 http://dx.doi.org/10.1093/toxsci/kfad028 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Society of Toxicology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Biotransformation, Toxicokinetics, and Pharmacokinetics
Conolly, Rory B
Schroeter, Jeffry
Kimbell, Julia S
Clewell, Harvey
Andersen, Melvin E
Gentry, P Robinan
Updating the biologically based dose-response model for the nasal carcinogenicity of inhaled formaldehyde in the F344 rat
title Updating the biologically based dose-response model for the nasal carcinogenicity of inhaled formaldehyde in the F344 rat
title_full Updating the biologically based dose-response model for the nasal carcinogenicity of inhaled formaldehyde in the F344 rat
title_fullStr Updating the biologically based dose-response model for the nasal carcinogenicity of inhaled formaldehyde in the F344 rat
title_full_unstemmed Updating the biologically based dose-response model for the nasal carcinogenicity of inhaled formaldehyde in the F344 rat
title_short Updating the biologically based dose-response model for the nasal carcinogenicity of inhaled formaldehyde in the F344 rat
title_sort updating the biologically based dose-response model for the nasal carcinogenicity of inhaled formaldehyde in the f344 rat
topic Biotransformation, Toxicokinetics, and Pharmacokinetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176246/
https://www.ncbi.nlm.nih.gov/pubmed/36912747
http://dx.doi.org/10.1093/toxsci/kfad028
work_keys_str_mv AT conollyroryb updatingthebiologicallybaseddoseresponsemodelforthenasalcarcinogenicityofinhaledformaldehydeinthef344rat
AT schroeterjeffry updatingthebiologicallybaseddoseresponsemodelforthenasalcarcinogenicityofinhaledformaldehydeinthef344rat
AT kimbelljulias updatingthebiologicallybaseddoseresponsemodelforthenasalcarcinogenicityofinhaledformaldehydeinthef344rat
AT clewellharvey updatingthebiologicallybaseddoseresponsemodelforthenasalcarcinogenicityofinhaledformaldehydeinthef344rat
AT andersenmelvine updatingthebiologicallybaseddoseresponsemodelforthenasalcarcinogenicityofinhaledformaldehydeinthef344rat
AT gentryprobinan updatingthebiologicallybaseddoseresponsemodelforthenasalcarcinogenicityofinhaledformaldehydeinthef344rat